Patents Assigned to PurePharm Inc.
  • Method of topically applying glycopyrrolate solution using absorbent pad to reduce sweating
    Patent number: 9034368
    Abstract: This invention relates to a convenient and safe product and method of applying glycopyrrolate topically in order to reduce excessive sweating in localized areas for those who suffer from this condition. This invention also relates to combining oral and topical delivery of glycopyrrolate to reduce excessive sweating and minimize side effects. This invention also relates to a convenient and safe product and method of applying glycopyrrolate topically to areas of compensatory sweating after endoscopic thoracic sympathectomy.
    Type: Grant
    Filed: February 12, 2014
    Date of Patent: May 19, 2015
    Assignee: PUREPHARM INC.
    Inventor: Willem Wassenaar
  • METHOD OF TOPICALLY APPLYING GLYCOPYRROLATE SOLUTION USING ABSORBENT PAD TO REDUCE SWEATING
    Publication number: 20140161867
    Abstract: This invention relates to a convenient and safe product and method of applying glycopyrrolate topically in order to reduce excessive sweating in localized areas for those who suffer from this condition. This invention also relates to combining oral and topical delivery of glycopyrrolate to reduce excessive sweating and minimize side effects. This invention also relates to a convenient and safe product and method of applying glycopyrrolate topically to areas of compensatory sweating after endoscopic thoracic sympathectomy.
    Type: Application
    Filed: February 12, 2014
    Publication date: June 12, 2014
    Applicant: PUREPHARM INC.
    Inventor: Willem WASSENAAR
  • Method of topically applying glycopyrrolate solution using absorbent pad to reduce sweating
    Patent number: 8679524
    Abstract: This invention relates to a convenient and safe product and method of applying glycopyrrolate topically in order to reduce excessive sweating in localized areas for those who suffer from this condition. This invention also relates to combining oral and topical delivery of glycopyrrolate to reduce excessive sweating and minimize side effects. This invention also relates to a convenient and safe product and method of applying glycopyrrolate topically to areas of compensatory sweating after endoscopic thoracic sympathectomy.
    Type: Grant
    Filed: June 1, 2012
    Date of Patent: March 25, 2014
    Assignee: Purepharm Inc.
    Inventor: Willem Wassenaar
  • METHOD OF TOPICALLY APPLYING GLYCOPYRROLATE SOLUTION USING ABSORBENT PAD TO REDUCE SWEATING
    Publication number: 20120237573
    Abstract: This invention relates to a convenient and safe product and method of applying glycopyrrolate topically in order to reduce excessive sweating in localized areas for those who suffer from this condition. This invention also relates to combining oral and topical delivery of glycopyrrolate to reduce excessive sweating and minimize side effects. This invention also relates to a convenient and safe product and method of applying glycopyrrolate topically to areas of compensatory sweating after endoscopic thoracic sympathectomy.
    Type: Application
    Filed: June 1, 2012
    Publication date: September 20, 2012
    Applicant: PUREPHARM INC.
    Inventor: Willem WASSENAAR
  • Method of topically applying glycopyrrolate solution using absorbent pad to reduce sweating
    Patent number: 8252316
    Abstract: This invention relates to a convenient and safe product and method of applying glycopyrrolate topically in order to reduce excessive sweating in localized areas for those who suffer from this condition. This invention also relates to combining oral and topical delivery of glycopyrrolate to reduce excessive sweating and minimize side effects. This invention also relates to a convenient and safe product and method of applying glycopyrrolate topically to areas of compensatory sweating after endoscopic thoracic sympathectomy.
    Type: Grant
    Filed: March 28, 2006
    Date of Patent: August 28, 2012
    Assignee: Purepharm Inc.
    Inventor: Willem Wassenaar
  • Nasal adaptation of an oral inhaler device
    Patent number: 7448385
    Abstract: This invention is for nasal adaptors for oral inhaler devices and methods of adapting an oral inhaler device with a nasal adaptor. The nasal adaptor of the present invention, in assembly with an oral metered dose aerosol inhaler converts an oral inhaler device to nasal delivery. The nasal adaptor in assembly with an oral inhaler device when in operation, simultaneously administers an inhalant to the nasal mucosa and down to the bronchial tree and lungs. In this manner a nasally delivered anti-inflammatory agent would travel down the same route as an allergen would—the nostril, nasal cavity, nasopharynx, trachea, bronchi and lung tissues.
    Type: Grant
    Filed: June 7, 2004
    Date of Patent: November 11, 2008
    Assignee: Purepharm Inc.
    Inventors: Willem Wassenaar, Alex Sochaniwskyj
  • Topical glycopyrrolate product
    Patent number: 7060289
    Abstract: This invention relates to a convenient and safe product and method of applying glycopyrrolate topically in order to reduce excessive sweating in localized areas for those who suffer from this condition. This invention also relates to combining oral and topical delivery of glycopyrrolate to reduce excessive sweating and minimize side effects. This invention also relates to a convenient and safe product and method of applying glycopyrrolate topically to areas of compensatory sweating after endoscopic thoracic sympathectomy.
    Type: Grant
    Filed: May 8, 2002
    Date of Patent: June 13, 2006
    Assignee: PurePharm Inc.
    Inventor: Willem Wassenaar